MMA.INC Secures 50/50 Revenue Share Partnership for Peptide Recovery Products
MMA.INC entered an exclusive strategic marketing partnership with Precision Peptide to market U.S.-manufactured, third-party tested peptide recovery products across its global combat sports ecosystem. Under the deal, MMA.INC will receive 50% net revenue share in year one and 25% thereafter from MMA-sourced sales.
1. Partnership Details
MMA.INC signed an exclusive agreement with Precision Peptide to market U.S.-manufactured, third-party tested peptide recovery products across its digital and physical combat sports ecosystem, including TrainAlta, BJJLink and MixedMartialArts.com.
2. Commercial Terms and Financial Impact
Under the deal, MMA.INC will receive 50% of net revenue from MMA-sourced sales during the first 12 months and 25% thereafter, with no capital investment required, plus a 12-month revenue tail post-termination.
3. Strategic Rationale and Market Opportunity
This collaboration taps into the high-growth peptide recovery and longevity market, leveraging MMA.INC’s 530,000 user profiles, 75,000 active students and over 800 global gyms to capture demand for performance optimization and wellness solutions.